Literature DB >> 22926729

[Clinical outcomes, health-related quality of life, and cost-effectiveness of a 6-month community- based lifestyle program for adults at increased cardiovascular risk in lower Austria].

Ursula Reichenpfader1, Kylie Thaler, Anke Richter, Patricia Thieda, Gerald Gartlehner.   

Abstract

AIM: To investigate lifestyle intervention effects and cost-effectiveness of a structured 6-month exercise and nutrition program for individuals at high risk for cardiovascular disease.
METHODS: Uncontrolled before and after study with assessments at baseline and six months. Adults without existing cardiovascular disease (CVD) but at increased CVD risk were eligible. The analysis was done by intention-to-treat (last-observation-carried-forward). Incremental cost-effectiveness analysis was performed. Main outcome measures were changes in cardiovascular risk-factors (blood pressure, weight, body-mass index, serum lipids, blood glucose, smoking cessation, and exercise) and health-related quality of life.
RESULTS: A total of 356 adults (70.5% female; mean age 48.9 years; mean body mass index 32.4; drop-out 10.4%) participated. At 6 months significant favorable effects were observed in several cardiovascular risk outcomes, exercise behaviour and health related quality of life. At an average incremental cost per life year saved for the ITT-population of <euro> 22.474 the program can be considered cost-effective.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926729     DOI: 10.1007/s10354-012-0135-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  22 in total

1.  Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I.

Authors:  S M Grundy; T Bazzarre; J Cleeman; R B D'Agostino; M Hill; N Houston-Miller; W B Kannel; R Krauss; H M Krumholz; R M Lauer; I S Ockene; R C Pasternak; T Pearson; P M Ridker; D Wood
Journal:  Circulation       Date:  2000-01-04       Impact factor: 29.690

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  The impact of inclusion criteria in health economic assessments.

Authors:  Anke Richter; Patricia Thieda; Kylie Thaler; Gerald Gartlehner
Journal:  Appl Health Econ Health Policy       Date:  2011-05-01       Impact factor: 2.561

Review 4.  Multiple risk factor interventions for primary prevention of coronary heart disease.

Authors:  Shah Ebrahim; Fiona Taylor; Kirsten Ward; Andrew Beswick; Margaret Burke; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

Review 5.  Diet, nutrition and the prevention of hypertension and cardiovascular diseases.

Authors:  K Srinath Reddy; Martijn B Katan
Journal:  Public Health Nutr       Date:  2004-02       Impact factor: 4.022

6.  Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Authors:  Julia Hippisley-Cox; Carol Coupland; Yana Vinogradova; John Robson; Rubin Minhas; Aziz Sheikh; Peter Brindle
Journal:  BMJ       Date:  2008-06-23

Review 7.  Exercise or exercise and diet for preventing type 2 diabetes mellitus.

Authors:  Leonardo J Orozco; Ana Maria Buchleitner; Gabriel Gimenez-Perez; Marta Roqué I Figuls; Bernd Richter; Didac Mauricio
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

8.  Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.

Authors:  Dieter Korczak; Markus Dietl; Gerlinde Steinhauser
Journal:  GMS Health Technol Assess       Date:  2011-04-01

Review 9.  The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study.

Authors:  Eveline Nüesch; Sven Trelle; Stephan Reichenbach; Anne W S Rutjes; Elizabeth Bürgi; Martin Scherer; Douglas G Altman; Peter Jüni
Journal:  BMJ       Date:  2009-09-07

10.  Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.

Authors:  Marshall Godwin; Lucia Ruhland; Ian Casson; Susan MacDonald; Dianne Delva; Richard Birtwhistle; Miu Lam; Rachelle Seguin
Journal:  BMC Med Res Methodol       Date:  2003-12-22       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.